McGill University Health Centre ( Site 0210)
Montreal, Quebec H4A 3J1
0 studies enrolling now · 2 studies all time
What they study most
Head and Neck Neoplasms, Small Cell Lung Cancer
Studies at this site
- Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — Running, not enrolling
- Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013) — Running, not enrolling